The biotransformation of chosen mycotoxins

• Autorzy: Gajecka M. , Jakimiuk E. , Zielonka L. , Obremski K. , Gajecki M.
• Języki publikacji: EN

Abstrakty

EN

Despite the unfavourable influence of mycotoxins on human and animal health and few toxi- cological aspects that have been documented, about these biologically active substances has not been explored. Aiming at more knowledge and a better understanding of the effects and mechanism of mycotoxin action in mammals would provide the basics for developing strategies to restrain different mycotoxicoses. One of the processes not fully understood is biotransformation, to which mycotoxins are subjected the animal organism. Biotransformation is the conversion of mycotoxins to non-toxic metabolites and occurs mostly in the intestinal mucosal membrane and liver, although other tissues and systems also take part in this process. Mycotoxin biotransformation reactions can be considered bioinactivation or detoxication, but mycotoxin biotransformation processes could also result in products more toxic than the mycotoxin. It can be concluded from research studies that our knowledge of mycotoxin biotransformation is scarce.

Słowa kluczowe

EN

mycotoxin; chosen mycotoxin; aflatoxin B1; ochratoxin A; deoxynivalenol; fumonisin; zearalenone; biotransformation; human health; animal health

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2009
• Tom: 12
• Numer: 2
• Opis fizyczny: p.293-303,fig.,ref.

Twórcy

autor

Gajecka M.

• University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-718 Olsztyn, Poland

autor

Jakimiuk E.

autor

Zielonka L.

autor

Obremski K.

autor

Gajecki M.

Bibliografia

• Berger V, Gabriel AF, Sergent T, Trouet A, Larondelle Y, Schneider YJ (2003) Interaction of ochratoxin A with human intestinal CaCo-2 cells: possible implication of a multidrug resistanceassociated proteins (MRP2). Toxi­col Lett 140-141:465-476.
• Boermans HJ, Leung MCK (2007) Mycotoxins and the pet food industry: Toxicological evidence and risk assess­ment. Int J Food Microbiol 119: 95-102.
• Caloni F, Spotti M, Auerbach H, Op den Camp H, Fink-Gremmels J, Pompa G (2000) In vitro metabolism of fumonisin B1 by ruminal microflora. Vet Res Commun 24: 379-387.
• Caloni F, Stammati A, Frigge G, De Angelis I (2006) Aflatoxin Ml absorption and cytotoxicity on human in­testinal in vitro model. Toxicon 47: 409-415.
• Cavret S, Lecoeur S (2006) Fusariotoxin transfer in animal. Food Chem Toxicol 44: 444-453.
• Chodorowski Z, Sein Anand J, Robakowska I, Klimek J, Kaletha K (2007) The role of intestine in detoxification. Przegląd Lekarski 64: 363-364.
• Chopra RC, Chabra A, Prasad KSN, Dudhe A, Murthy TN, Prasad T (1999) Carryover of Aflatoxin Ml in milk of cows fed aflatoxin B1 contaminated ration. Ind J Anim Nutr 16: 103-106.
• Czeczot H, Ścibior D, Skrzycki M, Podsiad M (2006) Activ­ity of antioxidant enzymes in patients with liver cirrhosis. Wiadomości Lekarskie 59: 762-766.
• Danicke S, Valenta H, Doll S (2004) On the toxicokinetics and the metabolism of deoxynivalenol (DON) in the pig. Arch Anim Nutr 58: 169-180.
• De Angelis I, Frigge G, Raimondi F, Stammati A, Zuccoc F, Caloni F (2005) Absorption of Fumonisin B1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein. Toxicon 45: 285-291.
• Deeley R.G., Westlake C., Cole S.P.C. (2006) Transmem­brane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86: 849-899.
• Degtiar WG, Kushlinsky NE (2001) 3a-hydroxysteroid de­hydrogenase in animal and human tissues. Biochemis- try-Moscow 66: 256-266.
• Eriksen GS, Pettersson H, Lindberg JE (2003) Absorption, metabolism and excretion of 3-acetyl DON in pigs. Arch Anim Nutr 57: 335-345.
• Fink-Gremmels J (2008) The role of mycotoxins in the health and performance of dairy cows. Vet J 176: 84-92.
• Fuchs S, Sontag G, Stidl R, Ehrlich V, Kundi M, Knasmiiller S (2008) Detoxification of patulin and ochratoxin A, two abundant mycotoxins, by lactic acid bacteria. Food Chem Toxicol 46: 1398-1407.
• Gajęcki M, Zielonka Ł, Obremski K, Jakimiuk E, Gajęcka M (2007) Multi-mycotoxicosis. Environ Biotechnol 1(3): 25-29.
• Galtier P (1999) Biotransformation and fate of micotoxins. J Toxicol-Toxin Rev 18: 295-312.
• Goyarts T, Danicke S, Briissow KP, Valenta H, Ueberschar KH, Tiemann U (2007) On the transfer of the Fusarium toxins deoxynivalenol (DON) and zearalenone (ZON) from sows to their fetuses during days 35-70 of gestation. Toxicol Lett 171: 38-49.
• Gouze ME, Laffitte J, Dedieu G, Galinier A, Thouvenot JP, Oswald IP, Galtier P (2005) Individual and combined effects of low oral doses of deoxynivalenol and nivalenol in mice. Cell Mol Biol 51 (Suppl): OL809-OL817.
• Hannemann F, Bichet A, Ewen KM, Bernhardt R (2007) Cytochrome P450 systems-biological variations of electron transport chains. Biochim Biophys Acta 1770: 330-344.
• Hussein HS, Brasel JM (2001) Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology 167: 101-134.
• Kimura M, Takahasi-Ando N, Nishiuchi T, Ohsato S, Tokai T, Ochiai N, Fujimura M, Kudo T, Hamamoto H, Yamaguchi I (2006) Molecular biology and biotechnol­ogy for reduction of Fusarium mycotoxin contamination. Pestic Biochem Physiol 86: 117-123.
• Kollarczik B, Gareis M, Hanelt M (1994) In vitro transform­ation of the Fusarium mycotoxins deoxynivalenol and zearalenone by the normal gut microflora of pigs. Nat Toxins 2: 105-110.
• Krajka-Kuźniak V (2007) Induction of phase II enzymes as a strategy in the chemoprevention of cancer and other degenerative diseases. Postępy Hig Med Dosw 61: 627-638.
• Liska DA, Lyon M, Jones DS (2006) Detoxification and bi- otransformational imbalances. Explore 2: 122-140.
• Leslie EM, Deeleyb RG, Coleb SPC (2005) Multidrug resis­tance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharm 204: 216- 237.
• Maciorowski KG, Herrera P, Jones FT, Pillai SD, Ricke SC (2007) Effects on poultry and livestock of feed contami­nation with bacteria and fungi. Anim Feed Sci Tech 133: 109-136.
• Malekinejad H, Maas-Bakker RF, Fink-Gremmels J (2005) Enzyme kinetics if zearalenone biotransformation: pH and cofactor effects. Arch Toxicol 79: 547-553.
• Malekinejad H, Colenbrander B, Fink-Gremmels J (2006A) Hydroxysteroid dehydrogenases in bovine and porcine granulose cells convert zearalenone into its hydroxylated metabolites a-zearalenol and (3-zearalenol. Vet Res Com­mun 30: 445-453.
• Malekinejad H, Maas-Bakker R, Fink-Gremmels J (2006B) Species differences in the hepatic biotransformation of zearalenone. Vet J 172: 96-102.
• Malekinejad H, Van Toi HTA, Fink-Gremmels J (2006C) Expression of 3a- and 3b-hydroxy steroid dehydrogenase mRNA in COCs and granulosa cells determines Zearalenone biotransformation. Toxicol in Vitro 20: 458-463.
• Martyn JF, Casqueiro J, Liras P (2005) Secretion systems for secondary metabolites: how producer cells send out mess­ages of intercellular communication. Curr Opin Microbi­ol 8: 282-293.
• McKean C, Tang L, Tang M, Billam M, Wang Z, Theodo- rakis CW, Kendall RJ, Wang J-S (2006) Comparative acute and combinative toxicity of aflatoxin B1 and fumonisin B1 in animals and human cells. Food Chem Toxicol 44: 868-876.
• Moss MO (2002) Risk assessment for aflatoxins in food­stuffs. Int Biodeter Biodegr 50: 137 - 142.
• Nebbia C (2001) Biotransformation enzymes as determi­nants of xenobiotic toxicity in domestic animals. Vet J 161: 238-252.
• Orsi RB, Oliveira CAF, Dilkin P, Xavier JG, Direito GM, Corręa B (2007) Effects of oral administration of aflatoxin B1 and fumonisin B1 in rabbits (Oiyctolagns cuniculus). Chem-Biol Interact 170: 201-208.
• Pestka JJ (2007) Deoxynivalenol: Toxicity, mechanisms and animal health risks. Anim Feed Sci Tech 137: 283-298.
• Piotrowska M, Żakowska Z (2005) The elimination of och- ratoxin A by lactic acid bacteria strains. Pol J Microbiol 54: 279-286.
• Richard JL (2007) Some major mycotoxins and their my- cotoxicoses - An overview. Int J Food Microbiol 119: 3-10.
• Riley RT, Voss KA (2006) Differential sensitivity of rat kid­ney and liver to fumonisin toxicity: organ-specific dif­ferences in toxin accumulation and sphingoid base me­tabolism. Toxicol Sci 92: 335-345.
• Ringot D, Chango A, Schneider YJ, Larondelle Y (2006) Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem-Biol Interact 159: 18-46.
• Sergent T, Parys M, Garsou S, Pussemier L, Schneider YJ, Larondelle Y (2006) Deoxynivalenol transport across hu­man intestinal Caco-2 cells and its effects on cellular me­tabolism at realistic intestinal concentrations. Toxicol Lett 164: 167-176.
• Sergent T, Ribonnet L, Kolosova A, Garsou S, Schaut A, De Saeger S, Van Peteghem C, Larondelle Y, Pussemier L, Schneider YJ (2008) Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food Chem Toxicol 46: 813-841.
• Shephard GS (2008) Impact of mycotoxins on human health in developing countries. Food Addit Contam 25(2): 146-151.
• Steckelbroeck S, Jin Y, Gopishetty S, Oyesanmi B, Penning TM (2004) Human cytosolic 3a-hydroxysteroid dehyd­rogenases of the aldo-keto reductase superfamily display significant 3bhydroxysteroid dehydrogenase activity: im­plications for steroid hormone metabolism and action. J Biol Chem 279: 10784-10795.
• Sundstol EG, Pettersson H (2003) Lack of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit Contam 20: 579-582.
• Theumer MG, Lopez AG, Aoki MP, Chnepa MC, Rubin­stein HR (2008) Subchronic mycotoxicoses in rats. His- topathological changes and modulation of the sphin- ganine to sphingosine (Sa/So) ratio imbalance induced by Fusarium verticillioides culture material, due to the co­existence of aflatoxin B1 in the diet. Food Chem Toxicol 46: 967-977.
• Tiemann U, Brüssow KP, Küchenmeister U, Jonas L, Pöh- land R, Reischauer A, Jäger K, Dänicke S (2008) Changes in the spleen and liver of pregnant sows and full-term piglets after feeding diets naturally con­taminated with deoxynivalenol and zearalenone. Vet J 176: 188-196.
• Tiemann U, Tomek W, Schneider F, Vanselow J (2003) Ef­fects of the micotoxins a- and ß-zearalenol on regulation of progesterone synthesis in cultured granulose cells from porcine ovaries. Reprod Toxicol 17: 673-681.
• Voss KA, Smith GW, Haschek WM (2007) Fumonisins: Toxicokinetics, mechanizm of action and toxicity. Anim Feed Sei Tech 137: 299-325.
• Wollenhaupta K, Jonas L, Tiemann U, Tomek W (2004) Influence of the mycotoxins a- and ß-zearalenol (ZOL) on regulators of cap-dependent translation control in pig endometrial cells. Reprod Toxicol 19: 189-199.
• Yiannikouris A, Jouany JP (2002) Mycotoxins in feeds and their fate in animals: a review. Anim Res 51: 81-99
• Yu Z, Hu D, Li Y (2004) Effects of zearalenone on mRNA expression and activity of cytochrome P450 1A1 and 1B1 in MCF-7 cells. Ecotoxicol Environ Saf 58: 187-193.
• Zinedine A, Soriano JM, Molto JC, Manes J (2007) Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: An oestrogenic mycotoxin. Food Chem Toxicol 45: 1-18.